Clinical Trial Update: Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 study assessing the effectiveness of a lopinavir/ritonavir–based regimen with lamivudine, efavirenz, and tenofovir disoproxil fumarate in HIV-infected p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Lamivudine (lamivudine)
• Lopinavir/ritonavir (lopinavir/ritonavir)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 2 | Status: COMPLETED